Trial Profile
A pilot clinical trial of reverse transcriptase inhibitors in children with Aicardi-Goutières syndrome (AGS)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Jan 2018
Price :
$35
*
At a glance
- Drugs Abacavir (Primary) ; Lamivudine (Primary) ; Zidovudine (Primary)
- Indications HIV infections
- Focus Pharmacodynamics
- 26 Jan 2018 Status changed from not stated to completed.
- 09 Oct 2017 New trial record